#relmada-therapeutics
Latest news and interesting information about relmada-therapeutics.
Relmada TX Q1 2026: Loss and stock dip
Relmada Therapeutics Q1 2026 results: stock declines, strong cash position and NDV-01 program in focus.
...
→
EN ▾
Hera Group Q1 2026: Steady growthKeysight Earnings: AI Testing Growth LimitsScotland WC 2026 squad announcedOxford Lane Capital NAV drops, stock dipsAgdam called Caucasus HiroshimaInMed Stock Surges 115% on Mentari Merger DealPezeshkian's Sensational ConfessionsVisibility to be limitedAzerbaijani wrestlers win medals in RussiaIsrael Strikes 25 Hezbollah Targets in LebanonHera Group Q1 2026: Steady growthKeysight Earnings: AI Testing Growth LimitsScotland WC 2026 squad announcedOxford Lane Capital NAV drops, stock dipsAgdam called Caucasus HiroshimaInMed Stock Surges 115% on Mentari Merger DealPezeshkian's Sensational ConfessionsVisibility to be limitedAzerbaijani wrestlers win medals in RussiaIsrael Strikes 25 Hezbollah Targets in Lebanon